# TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

> **NCT06137807** · NA · RECRUITING · sponsor: **P+F Products + Features USA Inc.** · enrollment: 50 (estimated)

## Conditions studied

- Tricuspid Regurgitation
- Tricuspid Valve Disease

## Interventions

- **DEVICE:** TricValve® Transcatheter Bicaval Valve System

## Key facts

- **NCT ID:** NCT06137807
- **Lead sponsor:** P+F Products + Features USA Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-23
- **Primary completion:** 2025-11
- **Final completion:** 2029-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-06-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06137807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06137807, "TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06137807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*